Deborah Crouch

Array ( [id] => 3997049 [patent_doc_number] => 05922685 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'IL-12 gene therapy of tumors' [patent_app_type] => 1 [patent_app_number] => 8/659206 [patent_app_country] => US [patent_app_date] => 1996-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 11926 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922685.pdf [firstpage_image] =>[orig_patent_app_number] => 659206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4344978 [patent_doc_number] => 06290949 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Adenoviral vector for inhibiting restenosis' [patent_app_type] => 1 [patent_app_number] => 8/653824 [patent_app_country] => US [patent_app_date] => 1996-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18430 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/290/06290949.pdf [firstpage_image] =>[orig_patent_app_number] => 653824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1309828 [patent_doc_number] => 06610288 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-26 [patent_title] => 'Porcine hepatocytes for use in treatment of disorders characterized by insufficient liver function' [patent_app_type] => B1 [patent_app_number] => 08/653059 [patent_app_country] => US [patent_app_date] => 1996-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 22965 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610288.pdf [firstpage_image] =>[orig_patent_app_number] => 08653059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3890055 [patent_doc_number] => 05777194 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'Gene-targeted mice with humanized A.beta. sequence and Swedish FAD mutation' [patent_app_type] => 1 [patent_app_number] => 8/636876 [patent_app_country] => US [patent_app_date] => 1996-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 37 [patent_no_of_words] => 13096 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/777/05777194.pdf [firstpage_image] =>[orig_patent_app_number] => 636876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4187573 [patent_doc_number] => 06153428 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => '.alpha.(1,3) galactosyltransferase negative porcine cells' [patent_app_type] => 1 [patent_app_number] => 8/621700 [patent_app_country] => US [patent_app_date] => 1996-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 3 [patent_no_of_words] => 8893 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153428.pdf [firstpage_image] =>[orig_patent_app_number] => 621700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3774699 [patent_doc_number] => 05850000 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Transgenic non-human mammals comprising a bovine 5\' flanking regulatory sequence' [patent_app_type] => 1 [patent_app_number] => 8/621100 [patent_app_country] => US [patent_app_date] => 1996-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 7566 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/850/05850000.pdf [firstpage_image] =>[orig_patent_app_number] => 621100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3891049 [patent_doc_number] => 05894078 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-13 [patent_title] => 'Transgenic mouse expressing C-100 app' [patent_app_type] => 1 [patent_app_number] => 8/607124 [patent_app_country] => US [patent_app_date] => 1996-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 17 [patent_no_of_words] => 7152 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/894/05894078.pdf [firstpage_image] =>[orig_patent_app_number] => 607124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4101228 [patent_doc_number] => 06066624 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-23 [patent_title] => 'Gene therapy for solid tumors using adenoviral vectors comprising suicide genes and cytokine genes' [patent_app_type] => 1 [patent_app_number] => 8/600942 [patent_app_country] => US [patent_app_date] => 1996-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 14614 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/066/06066624.pdf [firstpage_image] =>[orig_patent_app_number] => 600942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3993236 [patent_doc_number] => 05858351 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors' [patent_app_type] => 1 [patent_app_number] => 8/588355 [patent_app_country] => US [patent_app_date] => 1996-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12978 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858351.pdf [firstpage_image] =>[orig_patent_app_number] => 588355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4020670 [patent_doc_number] => 05907079 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-25 [patent_title] => 'MSH2 disrupted mice develop lymphomas' [patent_app_type] => 1 [patent_app_number] => 8/588521 [patent_app_country] => US [patent_app_date] => 1996-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9967 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/907/05907079.pdf [firstpage_image] =>[orig_patent_app_number] => 588521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3818681 [patent_doc_number] => 05789652 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'Non-insulin-dependent diabetic rat' [patent_app_type] => 1 [patent_app_number] => 8/568408 [patent_app_country] => US [patent_app_date] => 1995-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8668 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/789/05789652.pdf [firstpage_image] =>[orig_patent_app_number] => 568408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3850822 [patent_doc_number] => 05767099 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Cationic amphiphiles containing amino acid or dervatized amino acid groups for intracellular delivery of therapeutic molecules' [patent_app_type] => 1 [patent_app_number] => 8/546086 [patent_app_country] => US [patent_app_date] => 1995-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 25 [patent_no_of_words] => 26674 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767099.pdf [firstpage_image] =>[orig_patent_app_number] => 546086 [rel_patent_id] =>[rel_patent_doc_number] =>)